|
"yeh h i"的相關文件
顯示項目 171-180 / 210 (共21頁)
<< < 12 13 14 15 16 17 18 19 20 21 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2020 |
Cost-effectiveness of statin therapy for secondary prevention among patients with coronary artery disease and baseline LDL-C 70–100 mg/dL in Taiwan
|
FANG-JU LIN; Shyu K.-G.; Hsieh I.-C.; Huey-Herng Sheu W.; Tu S.-T.; Yeh S.-J.; Chen C.-I.; Lu K.-C.; Wu C.-C.; Shau W.-Y.; Inocencio T.J.; Wen Y.-C.; Yeh H.-I. |
| 國立成功大學 |
2020 |
2020 consensus of taiwan society of cardiology on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases
|
Chiang, Chiang C.-E.;Ueng, K.-C.;Chao, T.-H.;Lin, T.-H.;Wu, Y.-J.;Wang, K.-L.;Sung, Sung S.-H.;Yeh, H.-I.;Li, Y.-H.;Liu, P.-Y.;Chang, K.-C.;Shyu, K.-G.;Huang, J.-L.;Tsai, C.-D.;Hung, Hung H.-F.;Liu, M.-E.;Chao, T.-F.;Cheng, S.-M.;Cheng, H.-M.;Chu, P.-H.;Yin, W.-H.;Wu, Y.-W.;Chen, W.-J.;Lai, W.-T.;Lin, S.-J.;Yeh, S.-J.;Hwang, J.-J. |
| 國立成功大學 |
2020 |
Prognostic effect of high-density lipoprotein cholesterol level in patients with atherosclerotic cardiovascular disease under statin treatment
|
Li, Y.-H.;Tseng, W.-K.;Yin, W.-H.;Lin, F.-J.;Wu, Y.-W.;Hsieh, I.-C.;Lin, T.-H.;Sheu, W.H.-H.;Yeh, H.-I.;Chen, J.-W.;Wu, C.-C.;Investigators, Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry |
| 國立成功大學 |
2020 |
A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan
|
Li, Y.-H.;Chen, J.-W.;Lin, T.-H.;Wang, Y.-C.;Wu, C.-C.;Yeh, H.-I.;Huang, C.-C.;Chang, K.-C.;Wu, C.-K.;Chen, P.-W.;Huang, C.-W.;Chen, Z.-C.;Chang, W.-T.;Huang, W.-C.;Wang, C.-Y.;Lee, M.-Y.;Chao, A.-C.;Fu, W.-R.;Tsai, L.-K.;Tang, S.-C.;Chan, H.-L.;Yang, Yang Y.-C.;Wu, Y.-W.;Hwang, J.-J.;Lin, J.-L. |
| 臺大學術典藏 |
2019-08-27T07:33:21Z |
Membrane proteomics of impaired energetics and cytoskeletal disorganization in elderly diet-induced diabetic mice
|
Lam, C.S.P.;Lee, H.-C.;Liu, C.-Y.;Yeh, H.-I.;Chiau, J.-S.C.;Lai, Y.-J.;Shih, S.-C.;Su, C.-H.;Hsu, Y.-L.;Chang, C.-W.;Han, C.-L.;SZU-HUA PAN;Hung, C.-L.; Hung, C.-L.; SZU-HUA PAN; Han, C.-L.; Chang, C.-W.; Hsu, Y.-L.; Su, C.-H.; Shih, S.-C.; Lai, Y.-J.; Chiau, J.-S.C.; Yeh, H.-I.; Liu, C.-Y.; Lee, H.-C.; Lam, C.S.P. |
| 臺大學術典藏 |
2019-07-09T08:15:05Z |
Erratum: ‘Corrigendum to “2017 Taiwan lipid guidelines for high risk patients” [Journal of the Formosan Medical Association (2017) [217–248]’(S0929664616304302)(10.1016/j.jfma.2016.11.013)
|
The Writing Group Of 2017 Taiwan Lipid Guidelines For High Risk Patients;Yeh H.-I.;Wu C.-C.;Chen J.-W.;Yu T.-Y.;Lee C.-C.;Tang S.-C.;Liou C.-W.;Chien S.-C.;Su C.-H.;Liu P.-Y.;Chao T.-H.;Wang C.-Y.;Kuo-Liong Chien;Lin T.-H.;Charng M.-J.;Jeng J.-S.;Ueng K.-C.;Li Y.-H.; Li Y.-H.; Ueng K.-C.; Jeng J.-S.; Charng M.-J.; Lin T.-H.; KUO-LIONG CHIEN; Wang C.-Y.; Chao T.-H.; Liu P.-Y.; Su C.-H.; Chien S.-C.; Liou C.-W.; Tang S.-C.; Lee C.-C.; Yu T.-Y.; Chen J.-W.; Wu C.-C.; Yeh H.-I.; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients |
| 國立交通大學 |
2019-04-02T05:58:12Z |
Interrelation of transport and optical properties in gold nanoclusters
|
Shu, G. W.; Chen, T. Y.; Shen, J. L.; Lin, C. A. J.; Chang, W. H.; Chan, W. H.; Wang, H. H.; Yeh, H. I.; Chou, W. C. |
| 臺大學術典藏 |
2019 |
Impact of type D personality on clinical outcomes in Asian patients with stable coronary artery disease
|
Leu H.-B.;Yin W.-H.;Tseng W.-K.;Wu Y.-W.;Lin T.-H.;Yeh H.-I.;Cheng Chang K.;Wang J.-H.;Chau-Chung Wu;Chen J.-W.; Leu H.-B.; Yin W.-H.; Chen J.-W.; Tseng W.-K.; Wu Y.-W.; Lin T.-H.; Yeh H.-I.; Cheng Chang K.; Wang J.-H.; CHAU-CHUNG WU |
| 臺大學術典藏 |
2019 |
The correlation between waist-hip ratio and achieving therapeutic lipid goals in Taiwan
|
Wu C.-C.; Chen J.-W.; Lin F.-J.; Hsuan C.-F.; YEN-WEN WU; Huang L.-C.; Lin T.-H.; Chang K.-C.; Li Y.-H.; Yeh H.-I.; Yin W.-H.; Tseng W.-K.; Tsai H.-S. |
| 國立成功大學 |
2019 |
Antithrombotic treatment for symptomatic peripheral artery disease
|
Li, Y.-H.;Yeh, H.-I.;Hwang, J.-J. |
顯示項目 171-180 / 210 (共21頁)
<< < 12 13 14 15 16 17 18 19 20 21 > >>
每頁顯示[10|25|50]項目
|
